Immunogenicity of CD63 in a patient with melanoma

Melanoma Research

Volumn 7, Issue SUPPL. 2, 1997, Pages

  Smith, Melanie ^a   Bleijs, Rik ^a   Radford, Kristen ^a   Mersey, Peter ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

CD63; cDNA libraries; Human antisera; Immune responses; Melanoma

Indexed keywords

CD63 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOLOGY; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; MELANOMA; PRIORITY JOURNAL;

EID: 0030727122     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199708001-00025     Document Type: Article

References (27)

1. Atkinson B, Ernst CS, Ghrist BFD, et al. Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors. Hybridoma 1985; 4:243-255.
2. Sikora LKJ, Pinto A, Demetrick DJ, et al. Characterization of a novel neuroglandular antigen (NGA) expressed on abnormal human melanocytes. Int J Cancer 1987; 39:138-145.
3. Mackic RM, Camphell L, Turbitt ML. The use of NKI/C-3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. J Clin Pathol 1984; 37:367-372.
4. Van Duinen SG, Ruiter DJ, Hageman P, et al. Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanoma cancer Cancer 1984; 53:1566-1573.
5. Demetrick DJ, Herlyn D, Tretiak M, et al. ME491 melanoma-associated glycoprotein family: antigenic identity of ME491, NK1/C-3, neuroglandular antigen (NGA), and CD63 proteins. J Natl Cancer Inst 1992; 84:422-429.
6. Metzelaar MJ, Wijngaard PLJ, Peters PJ, et al. CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 1991; 266:3239-3245.
7. Wright MD, Tomlinson MG. The ins and outs of the transmembrane 4 superfamily. Immunol Today 1994; 15:588-594.
8. Kondoh M, Ueda M, Ichihashi M, Mishima Y. Decreased expression of human melanoma-associated antigen ME491 along the progression of melanoma pre-canceroses to invasive and metastatic melanomas. Melanoma Res 1993; 3:241-245.
9. Dixon WT, Demetrick DJ, Ohyama K, et al. Biosynthesis, glycosylation and intracellular processing of the neuroglandular antigen, a human melanoma-associated antigen. Cancer Res 1990; 50:4557-4565.
10. Gruters RA, Calafat J, Vennegoor CJGM, Jansen H, Ploegh HL. Structural heterogeneity of a human melanoma-associated antigen. Cancer Res 1989; 49:459-465.
11. Vennegoor C, Calafat J, Hageman Ph, et al. Biochemical characterization and cellular localization of a formalin-resistant melanoma-associated antigen reacting with monoclonal antibody NKI/C-3. Int J Cancer 1985; 35:287-295.
12. Si Z, Hersey P. Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma. Int J Cancer 1993; 54:37-13.
13. Radford KJ, Thorne RF, Mersey P. CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with β1 integrins in human melanoma. Biochem BiophysRes Commun 1996; 222:13-18.
14. Berditchevski F, Zutter MM, Hemler ME. Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol Biol Cell 1996; 7:193-207.
15. Radford KJ, Thorne RF, Mersey P. Regulation of adhesion and motility by the CD63 molecule in a human melanoma cell line. J Immunol 1997; 158:3353-3358.
16. Radford KJ, Mallesch J, Mersey P. Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME49D. Int J Cancer 1995; 62:631-635.
17. Vennegoor C, Rumke P. Circulating melanoma-associated antigen detected by monoclonal antibody NKI/C-3. Cancer Immunol Immunotber 1986; 23:93-100.
18. Pope JH, Morrison L, Moss DJ, et al. Human malignant melanoma cell lines. Pathology 1979; 11:191-195.
19. Carrel S, Tosi R, Gross N, et al. Subsets of human Ia-like molecules defined by monoclonal antibodies. Mol Immunol 1981; 18:-403-408.
20. Moss DJ, Rickinson AB, Pope JH. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer 1978; 22:662-668.
21. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1982.
22. Mierendorf RC, Percy C, Young RA. Sequencing of RNA transcripts synthesized in vitro from plasmid-containing bacteriophages. Methods Enzymol 1987; 152:458-469.
23. Gendler SJ, Spicer AP, Lalani E-N, et al. Structure and biology of a carcinoma-associated mucin, MUC1. Am Rev Respir Dis 1991; 144 (suppl 3 part 2):S42-S47.
24. Hersey P. Melanoma peptides in treatment of melanoma. Life Sci 1996; 8:34-38.
25. Sahin U, Tured O, Schmitt H, et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 1995; 92:11810-11813.
26. Tureci O, Sahin U, Schobert I, et al. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 1996; 56:4766-4772.
27. Tureci O, Sahin U, Schobert I, et al. The new melanoma-associated antigen HOM-MEL-40 has a tyrosinase kinase binding domain and is coded by the SSX gene which is involved in the t(11;X) translocation in chondrosarcoma [abstract]. Proc Am Assoc Cancer Res 1996; 37:465.